Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShawbrook Group Regulatory News (SHAW)

Share Price Information for Shawbrook Group (SHAW)

Share Price is delayed by 15 minutes
Get Live Data
305.00    12.50 (4.27%)
Bid:
303.50
Ask:
306.00
Spread: 2.50 (0.824%)
Market Cap: £1.59b
SHAW Live PriceLast checked at - London Stock Exchange

Intraday Shawbrook Group Share Chart

Director/PDMR Shareholding

21 Feb 2017 14:37

RNS Number : 4652X
Shawbrook Group PLC
21 February 2017
 

21 February 2017

 

Shawbrook Group PLC

(the "Company")

 

Sale of shares to cover tax liabilities

 

As announced by the Company on 4 January 2016, in connection with Steve Pateman taking up his role as Chief Executive Officer of the Company, the Special Opportunities Fund (Guernsey) LP made a one-off grant to Steve Pateman of awards over 552,623 ordinary shares in the Company, which vest in accordance with a pre-determined schedule subject to continued service.

 

Following the vesting of awards over 149,681 ordinary shares in the Company on 18 February 2017 in accordance with the terms of the grant, 70,527 ordinary shares have been sold on behalf of Steve Pateman in accordance with the terms of the grant at a price of 269.2p pence per ordinary share to cover tax liabilities arising on vesting. Following this sale, Steve Pateman is interested in 368,741 ordinary shares representing 0.15% of the Company's issued share capital.

 

This notification is made in accordance with the Market Abuse Regulation, Article 19(3).

 

For further information please contact:

 

Daniel Rushbrook

Company Secretary

01277 358 184

 

 

The below is detail in accordance with the EU Market Abuse Regulation:

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Stephen Pateman

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Executive Officer

 

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Shawbrook Group plc

b)

 

LEI

 

21380071539WSMTM4410

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares in Shawbrook Group plc of 1p each

 

 

GB00BWDPMF43

 

b)

 

Nature of the transaction

 

Sale of shares to cover tax liability on vesting

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

 

 

 

 

Price(s)

 

Volume(s)

1.

269.2p

70,527

 

 

d)

 

Aggregated information

- Aggregated volume

 

- Price

 

 

 

70,527 Ordinary shares of 1p

 

£189,834

e)

 

Date of the transaction

 

 

20 February 2017

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHZFLFLDLFXBBE
Date   Source Headline
21st May 20264:12 pmRNSResult of AGM
21st May 20261:41 pmRNSResidential Mortgage-Backed Securities May 2026
14th May 20267:00 amRNSShawbrook Q1 2026 Trading Update
6th May 202610:29 amRNSTender Offer Results Announcement
5th May 20266:24 pmRNSRecent media coverage
28th Apr 20264:52 pmRNSSuccessful Pricing of £250 million AT1 Securities
27th Apr 20269:16 amRNSTender Offer Announcement - AT1 Securities
24th Apr 20264:04 pmRNSNotice of AGM
24th Apr 202612:41 pmRNSHolding(s) in Company
20th Apr 20263:10 pmRNSDirector/PDMR Shareholding
9th Apr 20264:25 pmRNSHolding(s) in Company
9th Apr 20264:19 pmRNSDirector/PDMR Shareholding
25th Mar 20262:52 pmRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSShawbrook Full Year 2025 Results
12th Mar 20267:00 amRNSShawbrook Full Year 2025 Results
19th Feb 20265:00 pmRNSAppointment of Joint Corporate Brokers
14th Jan 20265:00 pmRNSDirector/PDMR Shareholding
8th Jan 20265:07 pmRNSDirector/PDMR Shareholding
16th Dec 20255:00 pmRNSDirector/PDMR Shareholding
4th Dec 20255:00 pmRNSResidential Mortgage-Backed Securities December 25
4th Dec 20257:00 amRNSInclusion in the FTSE 250 Index
28th Nov 20255:14 pmRNSShawbrook Group plc Post-Stabilisation Notice
28th Nov 20255:09 pmRNSExercise of Over-allotment Option
24th Nov 20255:27 pmRNSShawbrook Group plc Mid-Stabilisation Notice
13th Nov 20257:00 amRNSShawbrook Group plc Mid-Stabilisation Notice
13th Nov 20257:00 amRNSShawbrook Q3 2025 Trading Update
4th Nov 20251:16 pmRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSAdmission to trading on the London Stock Exchange
30th Oct 20257:00 amRNSAnnouncement of Pricing and Offer Size
9th Aug 20179:13 amRNSAdditional Listing
1st Aug 20173:49 pmRNSDate of cancellation of listing
1st Aug 20173:43 pmRNSTR-1 - Notification of Major Interest in Shares
27th Jul 201710:40 amRNSExercise of Options and Acceptance of Offer
26th Jul 201712:04 pmRNSExercise of Options and Acceptance of Offer
25th Jul 20173:31 pmRNSExercise of Options and Acceptance of Offer
19th Jul 20173:42 pmRNSCompulsory acquisition of Shawbrook shares
12th Jul 20175:00 pmRNSUpdate on Final Offer and Compulsory Acquisition
11th Jul 201711:30 amRNSPDMR Dealing - Amendment and Initial Notification
10th Jul 20172:58 pmRNSPDMR Dealing - Acceptance of the Offer
7th Jul 20176:16 pmRNSFinal offer declared unconditional in all respects
5th Jul 201711:05 amRNSNotification of Transactions of a PDMR
30th Jun 201710:27 amRNSForm 8.5 (EPT/NON-RI)
26th Jun 201710:19 amRNSTR-1: Notification of Major Interest in Shares
23rd Jun 201710:58 amRNSTR-1 - Notification of Major Interest in Shares
23rd Jun 20179:00 amRNSNotification of Transactions of PDMR
21st Jun 20175:42 pmRNSForm 8.3 - Shawbrook Group Plc
20th Jun 20173:20 pmRNSForm 8.3 - Shawbrook Group Plc
20th Jun 201711:43 amRNSForm 8.5 (EPT/RI)
20th Jun 201711:22 amRNSForm 8.5 (EPT/RI)
20th Jun 20179:36 amRNSForm 8.5 (EPT/RI) - Shawbrook Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.